Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atazanavir PK and Safety in HIV-Infected Children and Adolescents
NCT00006604Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2000
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2000; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00006604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006604.